Trial · NCT01298323
Adverse events202
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 202
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Asthenia | General disorders | Vandetanib 300mg | 12 | 103 | 13 |
| other | Asthenia | General disorders | Vandetanib 300mg + Outreach Program | 12 | 102 | 14 |
| other | Headache | Nervous system disorders | Vandetanib 300mg | 8 | 103 | 9 |
| other | Headache | Nervous system disorders | Vandetanib 300mg + Outreach Program | 12 | 102 | 16 |
| other | Erythema | Skin and subcutaneous tissue disorders | Vandetanib 300mg | 2 | 103 | 2 |
| other | Erythema | Skin and subcutaneous tissue disorders | Vandetanib 300mg + Outreach Program | 6 | 102 | 6 |
| other | Rash | Skin and subcutaneous tissue disorders | Vandetanib 300mg | 25 | 103 | 31 |
| other | Rash | Skin and subcutaneous tissue disorders | Vandetanib 300mg + Outreach Program | 26 | 102 | 28 |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Vandetanib 300mg | 7 | 103 | 7 |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Vandetanib 300mg + Outreach Program | 4 | 102 | 4 |
| other | Hypothyroidism | Endocrine disorders | Vandetanib 300mg | 15 | 103 | 16 |
| other | Hypothyroidism | Endocrine disorders | Vandetanib 300mg + Outreach Program | 15 | 102 | 16 |
| other | Constipation | Gastrointestinal disorders | Vandetanib 300mg | 5 | 103 | 5 |
| other | Constipation | Gastrointestinal disorders | Vandetanib 300mg + Outreach Program | 8 | 102 | 9 |
| other | Diarrhoea | Gastrointestinal disorders | Vandetanib 300mg | 48 | 103 | 63 |
| other | Diarrhoea | Gastrointestinal disorders | Vandetanib 300mg + Outreach Program | 55 | 102 | 85 |
| other | Dry mouth | Gastrointestinal disorders | Vandetanib 300mg | 4 | 103 | 4 |
| other | Dry mouth | Gastrointestinal disorders | Vandetanib 300mg + Outreach Program | 7 | 102 | 7 |
| other | Nausea | Gastrointestinal disorders | Vandetanib 300mg | 19 | 103 | 21 |
| other | Nausea | Gastrointestinal disorders | Vandetanib 300mg + Outreach Program | 26 | 102 | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01298323/events